Access to antivenoms in the developing world: A multidisciplinary analysis
Access to safe, effective, quality-assured antivenom products that are tailored to endemic venomous snake species is a crucial component of recent coordinated efforts to reduce the global burden of snakebite envenoming. Multiple access barriers may affect the journey of antivenoms from manufacturers...
Guardado en:
Autores principales: | Julien Potet, David Beran, Nicolas Ray, Gabriel Alcoba, Abdulrazaq Garba Habib, Garba Iliyasu, Benjamin Waldmann, Ravikar Ralph, Mohammad Abul Faiz, Wuelton Marcelo Monteiro, Jacqueline de Almeida Gonçalves Sachett, Jose Luis di Fabio, María de los Ángeles Cortés, Nicholas I. Brown, David J. Williams |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b2c397d294794db7b5b32adfc170db5b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessing a 6-h endpoint observation time in the lethality neutralization assay used to evaluate the preclinical efficacy of snake antivenoms
por: Gina Durán, et al.
Publicado: (2021) -
Safety assessment of β-fructofuranosidase from
por: Trung Duc Vo, et al.
Publicado: (2021) -
Genotoxicity Assessment and Protective Effect of Anogeissus leiocarpus Roots against Cyclophosphamide-Induced DNA Damage In Vivo
por: Aku Enam Motto, et al.
Publicado: (2021) -
Differential receptor tyrosine kinase phosphorylation in the uterus of rats following developmental exposure to tetrabromobisphenol A
por: Lysandra Castro, et al.
Publicado: (2021) -
Co-exposure of sodium arsenite and uranyl acetate differentially alters gene expression in CD3/CD28 activated CD4+ T-cells
por: Jodi R. Schilz, et al.
Publicado: (2021)